Edetate disodium Archives - Well Referenced

Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT)

This study analyzed data from the Trial to Assess Chelation Therapy (TACT) to evaluate whether edetate disodium chelation therapy provided different cardiovascular benefits based on the hypoglycemic treatment used by post-myocardial infarction (MI) patients with diabetes. Among 631 diabetic patients, those receiving insulin therapy experienced a significant reduction in major

June 26, 2025 No Comments

Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes

This review explores the link between toxic metal exposure and cardiovascular complications in diabetes, assessing the potential benefits of edetate disodium chelation therapy. The Trial to Assess Chelation Therapy (TACT) showed that diabetic patients with a history of myocardial infarction who received chelation therapy experienced a 41% reduction in recurrent

June 26, 2025 No Comments

Urinary Metal Levels after Repeated Edetate Disodium Infusions: Preliminary Findings

This clinical trial examined the impact of repeated edetate disodium infusions on urinary excretion levels of lead and cadmium in individuals with a history of myocardial infarction. The findings suggest that chelation therapy effectively reduced lead levels, which may help lower cardiovascular risks associated with lead toxicity, but did not

June 26, 2025 No Comments

Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients

This observational study evaluated the effects of edetate disodium-based chelation therapy in stable patients who had experienced either anterior or non-anterior myocardial infarctions (MIs). The findings suggested that patients with anterior MIs showed greater improvements in coronary plaque volume and cardiovascular health compared to those with non-anterior MIs, with statistically

June 26, 2025 No Comments

Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients

This article reviews the potential benefits of edetate disodium (a chelating agent) in post-myocardial infarction (MI) patients, particularly those with diabetes, for secondary prevention. The Trial to Assess Chelation Therapy (TACT) demonstrated that edetate disodium therapy led to significant cardiovascular improvements, especially in diabetic patients, showing comparable or superior benefits

June 26, 2025 No Comments

Enhanced vasculotoxic metal excretion in post-myocardial infarction patients following a single edetate disodium-based infusion

This study investigated the effectiveness of a single edetate disodium-based infusion in enhancing the excretion of vasculotoxic metals in patients who had experienced a myocardial infarction. The results showed a significant increase in the urinary excretion of lead, cadmium, and other metals post-infusion (p

June 26, 2025 No Comments

Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy

The review article explores the link between heavy metal accumulation, particularly lead and cadmium, and cardiovascular disease (CVD), highlighting findings from the Trial to Assess Chelation Therapy (TACT). The study suggests that chelation therapy with edetate disodium may help reduce cardiovascular events, especially in patients with diabetes, by removing toxic

June 26, 2025 No Comments

Limb Preservation Using Edetate Disodium-based Chelation in Patients with Diabetes and Critical Limb Ischemia: An Open-label Pilot Study

The open-label pilot study titled “Limb Preservation Using Edetate Disodium-based Chelation in Patients with Diabetes and Critical Limb Ischemia” evaluated the safety and efficacy of edetate disodium-based infusions in 10 diabetic patients with critical limb ischemia (CLI). Participants received up to 50 infusions, with assessments for safety, clinical efficacy, metal

June 26, 2025 No Comments

Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy

This article reviews the role of chronic toxic metal exposure in cardiovascular disease (CVD), highlighting the impact of metal chelation therapy, particularly using edetate disodium, as a secondary prevention method for cardiovascular events. It discusses the findings of the Trial to Assess Chelation Therapy (TACT), which demonstrated that chelation therapy

June 26, 2025 No Comments

Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005

This case report details three deaths, including two children, caused by severe hypocalcemia following chelation therapy with edetate disodium. The report highlights the risks associated with this therapy, specifically the potential for fatal cardiac arrest due to induced hypocalcemia. While edetate disodium is effective for treating heavy metal poisoning, the

June 26, 2025 No Comments

Tag: Edetate disodium